全文获取类型
收费全文 | 5501篇 |
免费 | 222篇 |
国内免费 | 85篇 |
专业分类
耳鼻咽喉 | 76篇 |
儿科学 | 32篇 |
妇产科学 | 609篇 |
基础医学 | 143篇 |
口腔科学 | 59篇 |
临床医学 | 266篇 |
内科学 | 575篇 |
皮肤病学 | 18篇 |
神经病学 | 74篇 |
特种医学 | 199篇 |
外科学 | 2966篇 |
综合类 | 184篇 |
现状与发展 | 1篇 |
预防医学 | 80篇 |
眼科学 | 4篇 |
药学 | 84篇 |
4篇 | |
中国医学 | 4篇 |
肿瘤学 | 430篇 |
出版年
2024年 | 8篇 |
2023年 | 215篇 |
2022年 | 383篇 |
2021年 | 417篇 |
2020年 | 456篇 |
2019年 | 215篇 |
2018年 | 284篇 |
2017年 | 132篇 |
2016年 | 224篇 |
2015年 | 221篇 |
2014年 | 440篇 |
2013年 | 363篇 |
2012年 | 333篇 |
2011年 | 324篇 |
2010年 | 288篇 |
2009年 | 197篇 |
2008年 | 177篇 |
2007年 | 188篇 |
2006年 | 143篇 |
2005年 | 119篇 |
2004年 | 101篇 |
2003年 | 100篇 |
2002年 | 92篇 |
2001年 | 88篇 |
2000年 | 63篇 |
1999年 | 60篇 |
1998年 | 38篇 |
1997年 | 18篇 |
1996年 | 25篇 |
1995年 | 26篇 |
1994年 | 10篇 |
1993年 | 10篇 |
1992年 | 10篇 |
1991年 | 8篇 |
1990年 | 7篇 |
1989年 | 7篇 |
1988年 | 7篇 |
1987年 | 4篇 |
1986年 | 7篇 |
排序方式: 共有5808条查询结果,搜索用时 15 毫秒
121.
《Burns : journal of the International Society for Burn Injuries》2019,45(3):627-640
ObjectiveBurn injury induces an acute hyperactive immune response followed by a chronic immune dysregulation that leaves those afflicted susceptible to multiple secondary infections. Many murine models are able to recapitulate the acute immune response to burn injury, yet few models are able to recapitulate long-term immune suppression and thus chronic susceptibility to bacterial infections seen in burn patients. This has hindered the field, making evaluation of the mechanisms responsible for these susceptibilities difficult to study. Herein we describe a novel mouse model of burn injury that promotes chronic immune suppression allowing for susceptibility to primary and secondary infections and thus allows for the evaluation of associated mechanisms.MethodsC57Bl/6 mice receiving a full-thickness contact burn were infected with Pseudomonas aeruginosa 14 days (primary infection) and/or 17 days (secondary infection) after burn or sham injury. The survival, pulmonary and systemic bacterial load as well as frequency and function of innate immune cells (neutrophils and macrophages) were evaluated.ResultsFollowing secondary infection, burn mice were less effective in clearance of bacteria compared to sham injured or burn mice following a primary infection. Following secondary infection both neutrophils and macrophages recruited to the airways exhibited reduced production of anti-bacterial reactive oxygen and nitrogen species and the pro-inflammatory cytokineIL-12 while macrophages demonstrated increased expression of the anti-inflammatory cytokine interleukin-10 compared to those from sham burned mice and/or burn mice receiving a primary infection. In addition the BALF from these mice contained significantly higher level so of the anti-inflammatory cytokine IL-4 compared to those from sham burned mice and/or burn mice receiving a primary infection.ConclusionsBurn-mediated protection from infection is transient, with a secondary infection inducing immune protection to collapse. Repeated infection leads to increased neutrophil and macrophage numbers in the lungs late after burn injury, with diminished innate immune cell function and an increased anti-inflammatory cytokine environment. 相似文献
122.
123.
124.
125.
126.
127.
128.
《The Journal of thoracic and cardiovascular surgery》2023,165(1):327-334.e2
ObjectiveSeveral trials have recently reported the safety of pulmonary resection after neoadjuvant immunotherapy with encouraging major pathological response rates. We report the detailed adverse events profile from a recently conducted randomized phase II trial in patients with resectable non–small cell lung cancer treated with neoadjuvant durvalumab alone or with sub-ablative radiation.MethodsWe conducted a randomized phase II trial in patients with non–small cell lung cancer clinical stages I to IIIA who were randomly assigned to receive neoadjuvant durvalumab alone or with sub-ablative radiation (8Gyx3). Secondary end points included the safety of 2 cycles of preoperative durvalumab with and without radiation followed by pulmonary resection. Postoperative adverse events within 30 days were recorded according to the National Cancer Institute Common Terminology Criteria for Adverse Events (version 4.0).ResultsSixty patients were enrolled and randomly assigned, with planned resection performed in 26 patients in each arm. Baseline demographics and clinical variables were balanced between groups. The median operative time was similar between arms: 128 minutes (97-201) versus 146 minutes (109-214) (P = .314). There was no 30- or 90-day mortality. Grade 3/4 adverse events occurred in 10 of 26 patients (38%) after monotherapy and in 10 of 26 patients (38%) after dual therapy. Anemia requiring transfusion and hypotension were the 2 most common adverse events. The median length of stay was similar between arms (5 days vs 4 days, P = .172).ConclusionsIn this randomized trial, the addition of sub-ablative focal radiation to durvalumab in the neoadjuvant setting was not associated with increased mortality or morbidity compared with neoadjuvant durvalumab alone. 相似文献
129.
130.